Thomas John Dietz

Thomas John Dietz is a declared insider at 3 companies (board member); the most frequent names are Cypherpunk Technologies Inc., Eiger BioPharmaceuticals, Inc. and Paratek Pharmaceuticals, Inc. In total, 9 filings cover trades dated from 16 February 2022 to 26 August 2026.

Market trades split into 1 purchase (€66k) and 2 sales (€54k). The net balance comes to €12k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 3 share grants and 2 option exercises. In 2026 alone, the filings show no purchases and 1 sale.

The newest entry dates from 27 August 2026: an open-market sale of €29k, in Cypherpunk Technologies Inc. The latest purchase dates back some time: it was published 1,362 days ago, on 25 January 2023. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.